Driehaus Capital Management LLC Halozyme Therapeutics, Inc. Transaction History

Driehaus Capital Management LLC

$10.2 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$33.32 - $42.1 $6.3 Million - $7.96 Million	-189,073 Reduced 36.31%	331,703 $12.3 Million
Q3 2023 Nov 14, 2023	BUY	$36.46 - $44.03 $66,320 - $80,090	1,819 Added 0.35%	520,776 $19.9 Million
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $554,033 - $708,825	18,297 Added 3.65%	518,957 $18.7 Million
Q1 2023 May 15, 2023	SELL	$32.86 - $55.7 $27.7 Million - $46.9 Million	-841,919 Reduced 62.71%	500,660 $19.1 Million
Q4 2022 Feb 14, 2023	SELL	$40.06 - $59.44 $152,508 - $226,288	-3,807 Reduced 0.28%	1,342,579 $76.4 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $2.46 Million - $3.31 Million	63,894 Added 4.98%	1,346,386 $53.2 Million
Q2 2022 Aug 15, 2022	BUY	$37.35 - $48.3 $16.4 Million - $21.2 Million	438,429 Added 51.94%	1,282,492 $56.4 Million
Q1 2022 May 16, 2022	BUY	$31.97 - $41.06 $8.29 Million - $10.6 Million	259,153 Added 44.31%	844,063 $33.7 Million
Q4 2021 Feb 14, 2022	SELL	$31.82 - $40.75 $7.83 Million - $10 Million	-246,184 Reduced 29.62%	584,910 $23.5 Million
Q3 2021 Nov 15, 2021	BUY	$38.47 - $46.42 $10.2 Million - $12.3 Million	264,635 Added 46.72%	831,094 $33.8 Million
Q2 2021 Aug 16, 2021	BUY	$38.84 - $51.31 $4.33 Million - $5.72 Million	111,446 Added 24.49%	566,459 $25.7 Million
Q1 2021 May 17, 2021	BUY	$39.51 - $51.45 $6.72 Million - $8.75 Million	170,067 Added 59.68%	455,013 $19 Million
Q4 2020 Feb 16, 2021	BUY	$25.81 - $43.62 $544,565 - $920,338	21,099 Added 8.0%	284,946 $12.2 Million
Q3 2020 Nov 16, 2020	BUY	$25.74 - $29.63 $432,818 - $498,228	16,815 Added 6.81%	263,847 $6.93 Million
Q2 2020 Aug 14, 2020	BUY	$16.25 - $26.81 $121,891 - $201,101	7,501 Added 3.13%	247,032 $6.62 Million
Q1 2020 May 15, 2020	BUY	$13.9 - $21.83 $3.33 Million - $5.23 Million	239,531 New	239,531 $4.31 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

Black Rock Inc. New York, NY

17.6M
Shares

$838 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

12.9M
Shares

$613 Million
0.01% of portfolio
State Street Corp Boston, MA

6.63M
Shares

$315 Million
0.02% of portfolio
Snyder Capital Management L P San Francisco, CA

4.06M
Shares

$193 Million
5.07% of portfolio
Alliancebernstein L.P. New York, NY

3.41M
Shares

$162 Million
0.07% of portfolio

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Driehaus Capital Management LLC with notifications on news.

Account